Status: PARTIAL — incomplete — unset metrics listed below; Currency: RUB; Amounts unit: millions; Forms: ✓ ✓ ✓
Report published: Not stored for this period — set financial_report_date on the row (EDGAR filingDate, KASE change_date, or manual_catalog).
Full financial report: Report (PDF)
PDF: Open the filing PDF (primary document)
To recalculate statement detection and previews from the PDF, use this link The default link runs in the background: a status panel shows phase, elapsed time, rough ETA, CUDA vs CPU, and OOM hints, then loads the finished report. Heavy mode with refresh does this automatically so reverse proxies do not return 502. Add &sync=1 only for one long blocking request (not recommended). You can use ?refresh=1, ?recalc=1, ?nocache=1, or ?recompute=1 on the URL. (block in the browser until done: synchronous refresh)
Default view is fast (metric table + statement page numbers only) so reverse proxies do not time out. Use ?heavy=1 when you need embedded page images and Camelot tables.
Metric values use dashboard units where applicable; evidence is the stored snippet from the PDF text layer or OCR used during extraction.
| Metric | Value | Evidence / page extract |
|---|---|---|
| Revenue | 43 455 | Row: MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), net profit 11,035 (+8%). EI1 left FY2025 income statement unextracted (balance sheet only). · dashboard=43,455.000 mln — MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), ne … |
| Operating profit | 10 440.29 | Row: identity: EBITDA - D&A on this row [rgap] · dashboard=10,440.289 mln — identity: EBITDA - D&A on this row [rgap] |
| D&A | 2 848.71 | Row: derived: same-row components · dashboard=2,848.711 mln — derived: same-row components |
| EBITDA | 13 289 | Row: MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), net profit 11,035 (+8%). EI1 left FY2025 income statement unextracted (balance sheet only). · dashboard=13,289.000 mln — MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), ne … |
| Net profit | 11 035 | Row: MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), net profit 11,035 (+8%). EI1 left FY2025 income statement unextracted (balance sheet only). · dashboard=11,035.000 mln — MD Medical Group FY2025 audited IFRS (mcclinics.ru ~2026-03-30; Interfax/smart-lab): revenue 43,455 mln RUB (+31%), EBITDA 13,289 (+24%), ne … |
| Cash | 2 729.3 | Row: EI1 log_ths cash_equivalents (2025 h2/2025 q4, pl=12) [rgap] · dashboard=2,729.299 mln — EI1 log_ths cash_equivalents (2025 h2/2025 q4, pl=12) [rgap] |
| Debt short | — | — |
| Debt long | — | — |
| Net debt | 3 178 | Row: EI1 curated EmitentFinancialData.NetDebt (replaces a naked stored net_debt with no debt-component backing that materially disagrees with the curated value - likely a mis-parse). · dashboard=3,178.000 mln — EI1 curated EmitentFinancialData.NetDebt (replaces a naked stored net_debt with no debt-component backing that materially disagrees with the … |
| Operating CF | 13 938.53 | — |
| Investing CF | -4 184.35 | — |
| Assets | 49 588.55 | — |
| Equity | 36 691.46 | — |
| EBITDA | 13 289 | 30.6% of revenue |
| − D&A | 2 849 | |
| = Operating profit (EBIT) | 10 440 | ✓ 24.0% of revenue |
| − Net finance costs, tax and other — derived | -595 | |
| = Net profit | 11 035 | 25.4% of revenue |
|---|
The finance-costs/tax line is derived as EBIT minus net profit; see the filing PDF above for the detailed split.
| ✓ | Balance sheet identity (A = L + E) | TA (49,589) ≈ TL (12,897) + TE (36,691); residual -0 within 1%. |
| ✗ | Net debt formula | Stored net_debt (3,178) ≠ derived from components (-2,729); diff +5,907 (185.9%). |
| ✓ | EBITDA = OP + D&A | EBITDA (13,289) ≈ OP (10,440) + D&A (2,849) = 13,289. |
| ✓ | Net profit vs operating profit | Net profit (11,035) sits within a plausible band vs operating profit (10,440). |
| ✓ | Cash ≤ total assets | Cash (2,729) ≤ total assets (49,589). |
| Form | Pages |
|---|---|
| P&L | — |
| BS | — |
| CF | — |
Page previews unavailable (missing PDF, no discovery pages, or PDF renderer not available).